| Date Filed | Type | Description |
| 04/15/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 03/31/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/31/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 03/31/2021 |
8-K
| Quarterly results |
| 03/31/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/31/2021 |
GN
| Oak Hill Capital Completes Acquisition of Otelco Inc. |
| 03/16/2021 |
8-K
| Quarterly results |
| 03/16/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/16/2021 |
GN
| Otelco Reports Fourth Quarter and 2020 Financial and Operational Results |
| 03/03/2021 |
GN
| OTELCO ANNOUNCES RELEASE DATE FOR FOURTH QUARTER AND 2020 RESULTS |
| 11/03/2020 |
8-K
| Quarterly results |
| 11/03/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 11/03/2020 |
GN
| Otelco Reports Third Quarter 2020 Financial and Operational Results |
| 10/14/2020 |
GN
| OTELCO ANNOUNCES RELEASE DATE FOR THIRD QUARTER 2020 RESULTS |
| 10/13/2020 |
8-K
| Quarterly results |
| 10/01/2020 |
8-K
| Quarterly results |
| 10/01/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 09/09/2020 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 09/01/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Otelco Inc. (NASDAQ: OTEL), Pfenex Inc. (NYSE: PFNX), Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), and Varian Medical Systems, Inc. (NYSE: VAR) |
| 08/20/2020 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
| 08/18/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Delmarva Bancshares, Inc. (DLMV), Maxim Integrated Products (MXIM), and Otelco Inc. (NASDAQ: OTEL) |
| 08/14/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Montage Resources Corporation (NYSE: MR), Noble Energy, Inc. (NASDAQ: NBL), and Otelco Inc. (NASDAQ: OTEL) |
| 08/04/2020 |
8-K
| Quarterly results |
| 08/04/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 08/04/2020 |
GN
| Otelco Reports Second Quarter 2020 Financial and Operational Results |
| 07/28/2020 |
GN
| OTELCO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of OTEL and Encourages Investors to Contact the Firm |
| 07/27/2020 |
GN
| OTELCO, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout |
| 07/27/2020 |
GN
| OTELCO ANNOUNCES RELEASE DATE FOR SECOND QUARTER 2020 RESULTS |
| 07/27/2020 |
8-K
| Quarterly results |
| 07/27/2020 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 07/27/2020 |
GN
| Otelco Agrees to be Acquired by Oak Hill Capital |
| 05/15/2020 |
8-K
| Quarterly results |
| 05/14/2020 |
8-K
| Quarterly results |
| 05/04/2020 |
8-K
| Quarterly results |
|